0
     

Report Added
Report already added
Global Prostate Cancer Diagnostics Market Analysis 2016-2020 and Forecast 2021-2026

Global Prostate Cancer Diagnostics Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot

The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
The global Prostate Cancer Diagnostics market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Prostate Cancer Diagnostics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Tumor Biomarker Tests
Imaging
Biopsy
Others

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Genomic Health
Abbott
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
< 55
55-75
> 75

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Prostate Cancer Diagnostics Industry
Figure Prostate Cancer Diagnostics Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Prostate Cancer Diagnostics
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Prostate Cancer Diagnostics
1.2.2 Downstream
Table Application Segment of Prostate Cancer Diagnostics
Table Global Prostate Cancer Diagnostics Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Prostate Cancer Diagnostics Market by Type
3.1 By Type
3.1.1 Tumor Biomarker Tests
Table Major Company List of Tumor Biomarker Tests
3.1.2 Imaging
Table Major Company List of Imaging
3.1.3 Biopsy
Table Major Company List of Biopsy
3.1.4 Others
Table Major Company List of Others
3.2 Market Size
Table Global Prostate Cancer Diagnostics Market 2016-2020, by Type, in USD Million
Figure Global Prostate Cancer Diagnostics Market Growth 2016-2020, by Type, in USD Million
Table Global Prostate Cancer Diagnostics Market 2016-2020, by Type, in Volume
Figure Global Prostate Cancer Diagnostics Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Prostate Cancer Diagnostics Market Forecast 2021-2026, by Type, in USD Million
Table Global Prostate Cancer Diagnostics Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Genomic Health (Company Profile, Sales Data etc.)
4.1.1 Genomic Health Profile
Table Genomic Health Overview List
4.1.2 Genomic Health Products & Services
4.1.3 Genomic Health Business Operation Conditions
Table Business Operation of Genomic Health (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Abbott (Company Profile, Sales Data etc.)
4.2.1 Abbott Profile
Table Abbott Overview List
4.2.2 Abbott Products & Services
4.2.3 Abbott Business Operation Conditions
Table Business Operation of Abbott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 OPKO (Company Profile, Sales Data etc.)
4.3.1 OPKO Profile
Table OPKO Overview List
4.3.2 OPKO Products & Services
4.3.3 OPKO Business Operation Conditions
Table Business Operation of OPKO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Siemens Healthcare (Company Profile, Sales Data etc.)
4.4.1 Siemens Healthcare Profile
Table Siemens Healthcare Overview List
4.4.2 Siemens Healthcare Products & Services
4.4.3 Siemens Healthcare Business Operation Conditions
Table Business Operation of Siemens Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 DiaSorin (Company Profile, Sales Data etc.)
4.5.1 DiaSorin Profile
Table DiaSorin Overview List
4.5.2 DiaSorin Products & Services
4.5.3 DiaSorin Business Operation Conditions
Table Business Operation of DiaSorin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 bioMeriux (Company Profile, Sales Data etc.)
4.6.1 bioMeriux Profile
Table bioMeriux Overview List
4.6.2 bioMeriux Products & Services
4.6.3 bioMeriux Business Operation Conditions
Table Business Operation of bioMeriux (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Roche (Company Profile, Sales Data etc.)
4.7.1 Roche Profile
Table Roche Overview List
4.7.2 Roche Products & Services
4.7.3 Roche Business Operation Conditions
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 MDx Health (Company Profile, Sales Data etc.)
4.8.1 MDx Health Profile
Table MDx Health Overview List
4.8.2 MDx Health Products & Services
4.8.3 MDx Health Business Operation Conditions
Table Business Operation of MDx Health (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Beckman Coulter (Company Profile, Sales Data etc.)
4.9.1 Beckman Coulter Profile
Table Beckman Coulter Overview List
4.9.2 Beckman Coulter Products & Services
4.9.3 Beckman Coulter Business Operation Conditions
Table Business Operation of Beckman Coulter (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Myriad Genetics (Company Profile, Sales Data etc.)
4.10.1 Myriad Genetics Profile
Table Myriad Genetics Overview List
4.10.2 Myriad Genetics Products & Services
4.10.3 Myriad Genetics Business Operation Conditions
Table Business Operation of Myriad Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Ambry Genetics (Company Profile, Sales Data etc.)
4.11.1 Ambry Genetics Profile
Table Ambry Genetics Overview List
4.11.2 Ambry Genetics Products & Services
4.11.3 Ambry Genetics Business Operation Conditions
Table Business Operation of Ambry Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Prostate Cancer Diagnostics Sales Revenue 2016-2020, by Company, in USD Million
Table Global Prostate Cancer Diagnostics Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Prostate Cancer Diagnostics Sales Revenue Share in 2020, by Company, in USD Million
Table Global Prostate Cancer Diagnostics Sales Volume 2016-2020, by Company, in Volume
Table Global Prostate Cancer Diagnostics Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Prostate Cancer Diagnostics Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Prostate Cancer Diagnostics Market Concentration, in 2020
Figure Europe Prostate Cancer Diagnostics Market Market Concentration, in 2020
Figure Asia-Pacific Prostate Cancer Diagnostics MMarket Concentration, in 2020
Figure South America Prostate Cancer Diagnostics Market Concentration, in 2020
Figure Middle East & Africa Prostate Cancer Diagnostics Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in < 55
Figure Prostate Cancer Diagnostics Demand in < 55, 2016-2020, in USD Million
Figure Prostate Cancer Diagnostics Demand in < 55, 2016-2020, in Volume
6.1.2 Demand in 55-75
Figure Prostate Cancer Diagnostics Demand in 55-75, 2016-2020, in USD Million
Figure Prostate Cancer Diagnostics Demand in 55-75, 2016-2020, in Volume
6.1.3 Demand in > 75
Figure Prostate Cancer Diagnostics Demand in > 75, 2016-2020, in USD Million
Figure Prostate Cancer Diagnostics Demand in > 75, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Prostate Cancer Diagnostics Demand Forecast 2021-2026, by Application, in USD Million
Figure Prostate Cancer Diagnostics Market Growth 2021-2026, by Application, in USD Million
Figure Prostate Cancer Diagnostics Market Share in 2026, by Application, in USD Million
Table Prostate Cancer Diagnostics Demand Forecast 2021-2026, by Application, in Volume
Table Prostate Cancer Diagnostics Market Growth 2021-2026, by Application, in Volume
Table Prostate Cancer Diagnostics Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Prostate Cancer Diagnostics Production 2016-2020, by Region, in USD Million
Table Prostate Cancer Diagnostics Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Prostate Cancer Diagnostics Market 2016-2020, by Region, in USD Million
Table Global Prostate Cancer Diagnostics Market Share 2016-2020, by Region, in USD Million
Table Global Prostate Cancer Diagnostics Market 2016-2020, by Region, in Volume
Table Global Prostate Cancer Diagnostics Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Prostate Cancer Diagnostics Market Size and Growth 2016-2020, in USD Million
Figure North America Prostate Cancer Diagnostics Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Prostate Cancer Diagnostics Market Size 2016-2020, by Country, in USD Million
Table North America Prostate Cancer Diagnostics Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Prostate Cancer Diagnostics Market Size and Growth 2016-2020, in USD Million
Figure Europe Prostate Cancer Diagnostics Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Prostate Cancer Diagnostics Market Size 2016-2020, by Country, in USD Million
Table Europe Prostate Cancer Diagnostics Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Prostate Cancer Diagnostics Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Prostate Cancer Diagnostics Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Prostate Cancer Diagnostics Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Prostate Cancer Diagnostics Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Prostate Cancer Diagnostics Market Size and Growth 2016-2020, in USD Million
Figure South America Prostate Cancer Diagnostics Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Prostate Cancer Diagnostics Market Size 2016-2020, by Country, in USD Million
Table South America Prostate Cancer Diagnostics Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Prostate Cancer Diagnostics Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Prostate Cancer Diagnostics Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Prostate Cancer Diagnostics Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Prostate Cancer Diagnostics Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Prostate Cancer Diagnostics Market Forecast 2021-2026, by Region, in USD Million
Table Prostate Cancer Diagnostics Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Table
1. Table Upstream Segment of Prostate Cancer Diagnostics
2. Table Application Segment of Prostate Cancer Diagnostics
3. Table Global Prostate Cancer Diagnostics Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Imaging
5. Table Major Company List of Biopsy
6. Table Major Company List of Others
7. Table Global Prostate Cancer Diagnostics Market 2016-2020, by Type, in USD Million
8. Table Global Prostate Cancer Diagnostics Market 2016-2020, by Type, in Volume
9. Table Global Prostate Cancer Diagnostics Market Forecast 2021-2026, by Type, in USD Million
10. Table Global Prostate Cancer Diagnostics Market Forecast 2021-2026, by Type, in Volume
11. Table Genomic Health Overview List
12. Table Business Operation of Genomic Health (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
13. Table Abbott Overview List
14. Table Business Operation of Abbott (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
15. Table OPKO Overview List
16. Table Business Operation of OPKO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table Siemens Healthcare Overview List
18. Table Business Operation of Siemens Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table DiaSorin Overview List
20. Table Business Operation of DiaSorin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table bioMeriux Overview List
22. Table Business Operation of bioMeriux (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table Roche Overview List
24. Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
25. Table MDx Health Overview List
26. Table Business Operation of MDx Health (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
27. Table Beckman Coulter Overview List
28. Table Business Operation of Beckman Coulter (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
29. Table Myriad Genetics Overview List
30. Table Business Operation of Myriad Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
31. Table Ambry Genetics Overview List
32. Table Business Operation of Ambry Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
33. Table Global Prostate Cancer Diagnostics Sales Revenue 2016-2020, by Company, in USD Million
34. Table Global Prostate Cancer Diagnostics Sales Revenue Share 2016-2020, by Company, in USD Million
35. Table Global Prostate Cancer Diagnostics Sales Volume 2016-2020, by Company, in Volume
36. Table Global Prostate Cancer Diagnostics Sales Volume Share 2016-2020, by Company, in Volume
37. Table Regional Demand Comparison List
38. Table Major Application in Different Regions
39. Table Prostate Cancer Diagnostics Demand Forecast 2021-2026, by Application, in USD Million
40. Table Prostate Cancer Diagnostics Demand Forecast 2021-2026, by Application, in Volume
41. Table Prostate Cancer Diagnostics Market Growth 2021-2026, by Application, in Volume
42. Table Prostate Cancer Diagnostics Market Share in 2026, by Application, in Volume
43. Table Prostate Cancer Diagnostics Production 2016-2020, by Region, in USD Million
44. Table Prostate Cancer Diagnostics Production 2016-2020, by Region, in Volume
45. Table Global Prostate Cancer Diagnostics Market 2016-2020, by Region, in USD Million
46. Table Global Prostate Cancer Diagnostics Market Share 2016-2020, by Region, in USD Million
47. Table Global Prostate Cancer Diagnostics Market 2016-2020, by Region, in Volume
48. Table Global Prostate Cancer Diagnostics Market Share 2016-2020, by Region, in Volume
49. Table North America Prostate Cancer Diagnostics Market Size 2016-2020, by Country, in USD Million
50. Table North America Prostate Cancer Diagnostics Market Size 2016-2020, by Country, in Volume
51. Table Europe Prostate Cancer Diagnostics Market Size 2016-2020, by Country, in USD Million
52. Table Europe Prostate Cancer Diagnostics Market Size 2016-2020, by Country, in Volume
53. Table Asia-Pacific Prostate Cancer Diagnostics Market Size 2016-2020, by Country, in USD Million
54. Table Asia-Pacific Prostate Cancer Diagnostics Market Size 2016-2020, by Country, in Volume
55. Table South America Prostate Cancer Diagnostics Market Size 2016-2020, by Country, in USD Million
56. Table South America Prostate Cancer Diagnostics Market Size 2016-2020, by Country, in Volume
57. Table Middle East & Africa Prostate Cancer Diagnostics Market Size 2016-2020, by Country, in USD Million
58. Table Middle East & Africa Prostate Cancer Diagnostics Market Size 2016-2020, by Country, in Volume
59. Table Prostate Cancer Diagnostics Market Forecast 2021-2026, by Region, in USD Million
60. Table Prostate Cancer Diagnostics Market Forecast 2021-2026, by Region, in Volume
61. Table Price Factors List

Report Title: Global Prostate Cancer Diagnostics Market Analysis 2016-2020 and Forecast 2021-2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW